Healthcare -
Biotechnology - NASDAQ - US
$ 10.14
-2.12 %
$ 764 M
Market Cap
-3.34
P/E
Price Target
Average
55.33%
Revenue Forecast
Estimate
-0.00%
EBIT
Estimate
18.92%
Net Income
Estimate
18.94%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Replimune Group, Inc.
Wall Street analysts predict an average 1-year price target for REPL of $15.8 , with forecasts ranging from
a
low of
$13 to a high of $19 .
REPL Lowest Price Target
Wall Street Target
13 USD
28.21%
REPL Average Price Target
Wall Street Target
15.8 USD
55.33%
REPL Highest Price Target
Wall Street Target
19 USD
87.38%
REVENUE FORECAST
Revenue Forecast Chart REPL
EBIT FORECAST
EBIT Forecast Chart REPL
NET INCOME FORECAST
Net Income Chart REPL